Djibouti pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$4.5 million | 100.0% |
| 3002 Human blood | US$1,000 | 0.0% |
| Product | Value | Share |
|---|---|---|
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$4.4 million | 99.4% |
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$27,000 | 0.6% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$1,000 | 0.0% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$33.0 million | 90.0% |
| 3006 Pharmaceutical goods | US$1.5 million | 4.2% |
| 3002 Human blood | US$1.5 million | 4.0% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$649,000 | 1.8% |
| 3003 Medicaments | US$45,000 | 0.1% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$8,000 | 0.0% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$27.6 million | 75.2% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$2.7 million | 7.4% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$1.2 million | 3.4% |
| 300660 Pharmaceutical goods: chemical contraceptive preparations based on hormones or spermicides | US$1.2 million | 3.3% |
| 300220 Vaccines: for human medicine | US$924,000 | 2.5% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$711,000 | 1.9% |
| 300590 Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | US$529,000 | 1.4% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$436,000 | 1.2% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$350,000 | 1.0% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$198,000 | 0.5% |
Shares are of Djibouti's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Djibouti's trade.
More Djibouti products
- 31 Fertilizers
- 15 Animal, vegetable or microbial fats and oils and their cleavage products
- 87 Vehicles
- 72 Iron and steel
- 85 Electrical machinery and equipment and parts thereof
- 39 Plastics and articles thereof
- 27 Mineral fuels, mineral oils and products of their distillation
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 17 Sugars and sugar confectionery
- 64 Footwear
- 10 Cereals
- 94 Furniture
Djibouti pharmaceutical products: questions and answers
How much pharmaceutical products does Djibouti export?
In 2024, Djibouti exported US$4.5 million of pharmaceutical products (HS chapter 30), 2.3% of its total exports. That ranks it 119 of 213 exporting countries in the data.
What are Djibouti's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$4.5 million), Human blood (3002, US$1,000).
How much pharmaceutical products does Djibouti import?
In 2024, Djibouti imported US$36.7 million of pharmaceutical products (HS chapter 30), 0.5% of its total imports. That ranks it 164 of 226 importing countries in the data.
What are Djibouti's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$33.0 million), Pharmaceutical goods (3006, US$1.5 million), Human blood (3002, US$1.5 million).
